Renal benefits of SGLT 2 inhibitors and GLP-1 receptor agonists: evidence supporting a paradigm shift in the medical management of type 2 diabetes - Ninčević, V; Omanović Kolarić, T; Roguljić, H (Int J Mol Sci, 2019)